Latest News about Mark Bleackley
Recent news which mentions Mark Bleackley
FDA Experts Weigh In On Incannex's CannQuit-O With Feedback On CBD As Treatment For Opioid Use Disorder
May 07, 2024
From Benzinga
Incannex Receives HREC Approval For Phase 2 Clinical Trial Of CBD-Based Drug For Use In Treatment Of Rheumatoid Arthritis
July 13, 2023
Tickers
IXHL
From Benzinga
Incannex Approved For Bioavailability Clinical Trial For Dronabinol-Based Drug For Treatment Of Obstructive Sleep Apnea
July 06, 2023
Tickers
IXHL
From Benzinga